These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1582791)

  • 21. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
    Vinores SA; Küchle M; Derevjanik NL; Henderer JD; Mahlow J; Green WR; Campochiaro PA
    Histol Histopathol; 1995 Oct; 10(4):913-23. PubMed ID: 8574012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine agonist regulation of outward active transport of fluorescein across retinal pigment epithelium in rabbits.
    Kawahara A; Hikichi T; Kitaya N; Takahashi J; Mori F; Yoshida A
    Exp Eye Res; 2005 Apr; 80(4):493-9. PubMed ID: 15781276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perturbation of the blood-retinal barrier after enzyme perfusion. A cytochemical study.
    Pino RM
    Lab Invest; 1987 May; 56(5):475-80. PubMed ID: 3573719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of blood-retinal barrier integrity.
    Vinores SA
    Histol Histopathol; 1995 Jan; 10(1):141-54. PubMed ID: 7756735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
    Ozaki H; Hayashi H; Vinores SA; Moromizato Y; Campochiaro PA; Oshima K
    Exp Eye Res; 1997 Apr; 64(4):505-17. PubMed ID: 9227268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakdown of the blood-retinal barrier in a model of retinal neovascularization.
    de Juan E; Wilson D; Hatchell D
    Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1108-15. PubMed ID: 2439473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Freeze-fracture and lanthanum studies of the retinal microvasculature in diabetic rats.
    Caldwell RB; Slapnick SM
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1610-9. PubMed ID: 1532791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.
    Metrikin DC; Wilson CA; Berkowitz BA; Lam MK; Wood GK; Peshock RM
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1361-70. PubMed ID: 7775114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Histochem J; 1993 Sep; 25(9):648-63. PubMed ID: 8226103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies.
    Campochiaro PA; Sen HA
    Arch Ophthalmol; 1989 Mar; 107(3):412-6. PubMed ID: 2493781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interendothelial junctions of the rabbit iris vasculature in anterior uveitis.
    Freddo TF; Sacks-Wilner R
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1104-11. PubMed ID: 2732025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular changes in the posterior segment in clinical and experimental ocular inflammatory disease.
    Lightman S
    Eye (Lond); 1991; 5 ( Pt 4)():432-7. PubMed ID: 1743359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.
    Bamforth SD; Lightman SL; Greenwood J
    Am J Pathol; 1997 Jan; 150(1):329-40. PubMed ID: 9006348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
    Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
    Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.